Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The highest level of viremia measured was 7 x 10(3) to 8 x 10(3) plaqueforming units per ml. No adverse reactions to the vaccine were observed in any horses, including 42 pregnant mares and their resulting foals.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D001831:Body Temperature; D004666:Encephalitis Virus, Venezuelan Equine / Q000302:isolation & purification; D004683:Encephalomyelitis, Equine / Q000097:blood / Q000276:immunology*; D006462:Hemolytic Plaque Technique; D006736:Horses / Q000276:immunology; D007109:Immunity; D007958:Leukocyte Count; D013997:Time Factors; D014765:Viral Vaccines / Q000009:adverse effects
D000914:Antibodies, Viral; D014765:Viral Vaccines